Synergism of ceftizoxime and tobramycin for Pseudomonas aeruginosa.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D015296:Ceftizoxime; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D051379:Mice; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D014031:Tobramycin / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D015296:Ceftizoxime; D002439:Cefotaxime; D014031:Tobramycin